Pharmaceutical Industry Information Portal

HomeNews

News

Laboratorios Richmond to provide with over 3 million doses of the second component of the Sputnik V vaccine

RDIF and partners facilitated the technology transfer to Laboratorios Richmond for the local production of the vaccine with the first batch manufactured in April 2021.

Antitrust watchdog sets maximum selling price for 50 doses of CoviVac vaccine at $297

FAS has agreed on the maximum selling price for a new package of the CoviVac vaccine. The new form of vaccine release contains 50 doses.

Kazakhstan’s Karaganda pharmaceutical plant ready to manufacture Sputnik Light vaccine

By now, the Karaganda plant has manufactured five million doses of the Sputnik V vaccine.

FAS initiated a case in the ALV supply market

The FAS Russia has initiated an antimonopoly case against Hamilton Medical AG on the grounds of coordinating the actions of the manufacturer's official distributors.

Sanofi acquires biotech company Translate Bio for $3.2 billion

Sanofi and Translate Bio have a shared commitment to innovation in the mRNA space.

Betuvax coronavirus vaccine clinical trials to begin in September

The Betuvax-CoV-2 is a split recombinant vaccine of the basis of spherical particles with the coronavirus surface antigen (protein).
spot_img

Expert Articles

spot_img